IV Ketamine for OCD: What the Research Shows
Can IV ketamine help obsessive-compulsive disorder? A Plano physician explains what the research shows, his clinical experience, and why therapy still matters.
Obsessive-compulsive disorder can be hard to treat. A physician explains what studies show about IV ketamine for OCD and how it fits with proven treatments.
By Jerron C. Hill, M.D., Anesthesiologist and Founder of HILLMED
Obsessive-compulsive disorder (OCD) is more than being neat or careful. People with OCD have unwanted, intrusive thoughts (obsessions) and feel driven to repeat certain actions or mental rituals (compulsions) to ease the distress those thoughts cause. These cycles can take hours each day and affect work, school and relationships.
About 2.3% of U.S. adults will have OCD at some point in their lives, and many also live with depression or anxiety. [1] Standard treatments help many people, but not everyone. That is one reason researchers have studied IV ketamine for OCD. In my recent video, I listed OCD among the conditions IV ketamine may help.
Watch: Dr. Hill explains which conditions IV ketamine may help, including OCD.
How OCD is usually treated
The two main treatments for OCD are a type of cognitive behavioral therapy called exposure and response prevention (ERP), and medications called serotonin reuptake inhibitors (SSRIs and clomipramine). A large analysis of 54 trials with 6,652 participants found that both therapy and these medications reduced OCD symptoms compared with placebo. [2]
These treatments have two limits. Medications often take two to three months to work, and many people still have symptoms after trying them. [3] Some people also find ERP hard to start when their anxiety is very high.
Why ketamine is being studied for OCD
Most OCD medications act on serotonin. Ketamine works differently. It acts on glutamate, the brain's main signaling chemical for learning and forming new connections. Research suggests glutamate plays a role in OCD, which led scientists to test whether ketamine could ease symptoms more quickly. [3]
What the research shows
A promising early trial. In a small randomized, placebo-controlled study at Columbia University, adults with near-constant obsessions received a single IV ketamine infusion. One week later, 50% of those who received ketamine met the criteria for treatment response, compared with none of those who received placebo. [3]
Mixed results. In another small study at Yale, people with long-standing, treatment-resistant OCD received one infusion. Their OCD symptoms improved only slightly, while depression symptoms improved more. [4] Results may depend on the patient and on other conditions, such as depression.
What reviews say. Recent reviews of all available studies found that ketamine often reduced OCD symptoms quickly, but the benefit after a single dose was often short-lived. [5, 6] Studies that combined ketamine with ERP therapy reported longer-lasting improvement, suggesting ketamine may open a window that makes therapy easier. [6, 7]
In short, the research is early and the studies are small. IV ketamine is not FDA-approved for OCD and is used off-label. It is not a first-line treatment, but it may be an option for some adults whose symptoms have not improved enough with standard care.
My clinical experience at HILLMED
In my practice, I’ve seen IV ketamine help ease depression and anxiety in patients who also have OCD. About half of the patients with OCD whom I’ve treated with IV ketamine also experienced a decrease in their OCD symptoms. That’s an observation from my practice. Larger, controlled clinical trials are needed to determine who is most likely to benefit and how long any improvement in OCD symptoms lasts.
Who may be a candidate
IV ketamine for OCD may be worth discussing if you:
Have OCD that has not improved enough with therapy and medication
Also live with depression, which ketamine has been studied for more extensively
Are working with, or willing to work with, a therapist on ERP
IV ketamine is not right for everyone. Every patient starts with a medical evaluation to review health history, medications and goals. Learn more about ketamine for treatment-resistant depression and ketamine for persistent anxiety.
Therapy still matters
Ketamine is not a replacement for OCD therapy. Based on the research, the best results may come when infusions are paired with ERP, which teaches the brain that the feared outcome does not happen when the compulsion is resisted. We encourage patients to continue therapy with their own provider during treatment.
At HILLMED, IV ketamine is part of a whole-person approach. Our wellness aftercare program focuses on stress management, mindfulness, nutrition, exercise and restorative sleep. Read more about mindfulness and mood disorders.
A note on safety
In studies, ketamine was generally well tolerated. [5] Common short-term effects during an infusion include feeling detached, changes in blood pressure and nausea, which usually fade soon after. A small number of people with OCD in research studies reported low mood, anxiety or suicidal thoughts a day or two after an infusion. [6, 8] That is why careful screening and follow-up matter. Every infusion at HILLMED is physician-supervised, and our team checks in after each session. Read what to expect at your first infusion.
Frequently asked questions
Can IV ketamine cure OCD?
No. Research suggests ketamine may reduce OCD symptoms for some people, but the effect of a single infusion is often temporary. It works best as part of a care plan that includes therapy.
How fast can ketamine work for OCD?
In the Columbia study, some people noticed fewer obsessions during the infusion itself, and half of the ketamine group met response criteria one week later. [3] Results vary from person to person.
Do I need to stop my OCD medication?
Not usually. Many patients continue their current medications. Never stop or change a medication without talking to the clinician who prescribes it.
When to seek help
Talk with a physician or mental health professional if intrusive thoughts or rituals take up more than an hour a day, cause distress or interfere with daily life.
If you are in crisis or thinking about suicide, call or text 988 to reach the 988 Suicide & Crisis Lifeline, or call 911.
Start with a conversation
If OCD, depression or anxiety is affecting your life, you do not have to manage it alone. Book a complimentary teleconference consultation or call HILLMED at 972.212.4341 to learn whether IV ketamine therapy may be right for you.
About the author
Jerron C. Hill, M.D., is an anesthesiologist and the founder of HILLMED in Plano, Texas, and Dr. CBD & Nutrition Centers in University Park. He brings decades of anesthesia experience and nine years of clinical experience treating patients with IV ketamine to individualized, physician-supervised care.
Selected references
Ruscio AM, et al. The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry. 2010;15(1):53-63.
Skapinakis P, et al. Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2016;3(8):730-739.
Rodriguez CI, et al. Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept. Neuropsychopharmacology. 2013;38(12):2475-2483.
Bloch MH, et al. Effects of ketamine in treatment-refractory obsessive-compulsive disorder. Biol Psychiatry. 2012;72(11):964-970.
Heroiu I, et al. Ketamine for the treatment of obsessive-compulsive disorder (OCD): a systematic review on efficacy and tolerability. Clin Neuropharmacol. 2026;49(6):235-240.
Eghdami S, et al. Efficacy and tolerability of ketamine in moderate to severe obsessive-compulsive disorder: a systematic review. Psychopharmacology (Berl). 2026. Online ahead of print.
Rodriguez CI, et al. Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? An open-label trial. J Clin Psychiatry. 2016;77(3):408-409.
Niciu MJ, et al. Two cases of delayed-onset suicidal ideation, dysphoria and anxiety after ketamine infusion in patients with obsessive-compulsive disorder and a history of major depressive disorder. J Psychopharmacol. 2013;27(7):651-654.
This article is for education only and is not medical advice. Talk with a physician or mental health professional about your individual situation.